Effect of ACTH, corticoids and PCN (pregnenolone-16 alpha-carbonitrile) alpha on drug response and disposition.
D000305:Adrenal Cortex Hormones / Q000494:pharmacology*; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D000814:Aniline Compounds / Q000037:antagonists & inhibitors; D000818:Animals; D002491:Central Nervous System Agents / Q000037:antagonists & inhibitors*; D002492:Central Nervous System Depressants / Q000037:antagonists & inhibitors*; D003345:Corticosterone / Q000494:pharmacology; D003692:Delayed-Action Preparations; D003900:Desoxycorticosterone / Q000494:pharmacology; D005260:Female; D005438:Fludrocortisone / Q000494:pharmacology; D006854:Hydrocortisone / Q000494:pharmacology; D011285:Pregnenolone Carbonitrile / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship; D014221:Triamcinolone / Q000494:pharmacology; D015049:Zoxazolamine / Q000037:antagonists & inhibitors
D000305:Adrenal Cortex Hormones; D000814:Aniline Compounds; D002491:Central Nervous System Agents; D002492:Central Nervous System Depressants; D003692:Delayed-Action Preparations; D011285:Pregnenolone Carbonitrile; D014221:Triamcinolone; D003900:Desoxycorticosterone; D000324:Adrenocorticotropic Hormone; D015049:Zoxazolamine; D005438:Fludrocortisone; D003345:Corticosterone; D006854:Hydrocortisone